Whitehawk Therapeutics (WHWK)

• Market cap: $126M
• 1 day: -0.74%
• 5 days: 8.98%
• 1 month: 16.09%
• 3 months: 37.63%
• 6 months: 40.53%
• Year to date: -14.97%
• 1 year: -13.87%
• 5 years: -82.55%
• 10 years: -95.44%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22